Vimarsana
Biggest News Aggregation in the World

Page 26 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

Compass Pathways Shares Rise 11% After Private Placement - Vimarsana News

Compass Pathways Shares Rise 11% After Private Placement

By Chris Wack Compass Pathways shares rose nearly 11% Wednesday after the company entered an agreement with healthcare specialist investors to purchase 16.1...

Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical ... - Vimarsana News

Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical ...

Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical ...

COMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by HC Wainwright - Vimarsana News

COMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a report published on Friday morning, Benzinga reports. The firm currently has a $120.00 price objective on the stock. Separately, EF Hutton Acquisition Co. I restated a buy rating and set a $38.00 target price on shares of COMPASS […]

COMPASS Pathways (NASDAQ:CMPS) Earns Buy Rating from HC Wainwright - Vimarsana News

COMPASS Pathways (NASDAQ:CMPS) Earns Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a report issued on Friday morning, Benzinga reports. The brokerage currently has a $120.00 target price on the stock. Separately, EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $38.00 target price on shares of COMPASS […]

COMPASS Pathways (NASDAQ:CMPS) Given Buy Rating at HC Wainwright - Vimarsana News

COMPASS Pathways (NASDAQ:CMPS) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. HC Wainwright currently has a $120.00 price objective on the stock. Separately, EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $38.00 price objective on […]

Source: wkrb13.com